Compare ABCL & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | ARI |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2020 | 2009 |
| Metric | ABCL | ARI |
|---|---|---|
| Price | $5.63 | $10.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $8.40 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 8.2M | 1.2M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 9.31% |
| EPS Growth | 10.91 | ★ 183.51 |
| EPS | N/A | ★ 0.16 |
| Revenue | $75,128,000.00 | ★ $271,589,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.85 | N/A |
| P/E Ratio | ★ N/A | $68.63 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.53 | $9.49 |
| 52 Week High | $6.79 | $11.24 |
| Indicator | ABCL | ARI |
|---|---|---|
| Relative Strength Index (RSI) | 55.07 | 50.90 |
| Support Level | $5.34 | $10.66 |
| Resistance Level | $5.63 | $11.14 |
| Average True Range (ATR) | 0.56 | 0.16 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 56.84 | 59.84 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.